https://orcid.org/0000-0001-7594-7280
Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Pawel Robak & Tadeusz Robak. (2023) Immunotherapy combinations for chronic lymphocytic leukemia: advantages and disadvantages. Expert Opinion on Biological Therapy 23:1, pages 21-35.
Read now
Read now
Ruth Alonso-Alonso, Marta Rodriguez, Daniel Morillo, Raul Cordoba & Miguel A Piris. (2020) An analysis of genetic targets for guiding clinical management of follicular lymphoma. Expert Review of Hematology 13:12, pages 1361-1372.
Read now
Read now
Articles from other publishers (17)
Michele Clerico, Simone Ragaini & Federica Cavallo. 2024. Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal. Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal
103
122
.
Sharafudeen Dahiru Abubakar, Stella Amarachi Ihim, Mansur Aliyu, Mohammad Saffarioun & Gholamreza Azizi. 2024. Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal. Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal
31
75
.
Anne Bordron, Marie Morel & Cristina Bagacean. 2024. Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal. Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal
231
247
.
Justine C. Noel, Daniel Lagassé, Basil Golding & Zuben E. Sauna. (2023) Emerging approaches to induce immune tolerance to therapeutic proteins. Trends in Pharmacological Sciences 44:12, pages 1028-1042.
Crossref
Crossref
Kashyap Kumar Dubey, Akshay Kumar, Anshu Baldia, Deepanshi Rajput, Suneel Kateriya, Rajani Singh, Nikita, Ravi Tandon & Yogendra Kumar Mishra. (2023) Biomanufacturing of glycosylated antibodies: Challenges, solutions, and future prospects. Biotechnology Advances 69, pages 108267.
Crossref
Crossref
Razan Mohty, Shaykha Alotaibi, Martha Gadd, Yan Luo, Ricardo Parrondo, Hong Qin & Mohamed A. Kharfan-Dabaja. (2023) Chimeric Antigen Receptor T-cell Therapy for Chronic Lymphocytic Leukemia: What is the supporting evidence so far?. Clinical Hematology International 5:4.
Crossref
Crossref
Magdalena Ostojska, Emilia Nowak, Julia Twardowska, Monika Lejman & Joanna Zawitkowska. (2023) CAR-T Cell Therapy in the Treatment of Pediatric Non-Hodgkin Lymphoma. Journal of Personalized Medicine 13:11, pages 1595.
Crossref
Crossref
Hairuo Wen, Xiaoyan Lou, Zhe Qu, Chao Qin, Hua Jiang, Ying Yang, Liqing Kang, Xingchao Geng, Lei Yu & Ying Huang. (2022) Pre-clinical efficacy of CD20-targeted chimeric antigen receptor T cells for non-Hodgkin's lymphoma. Discover Oncology 13:1.
Crossref
Crossref
Qian Cheng, Jingwen Tan, Rui Liu, Liqing Kang, Yi Zhang, Erhua Wang, Ying Li, Jian Zhang, Han Xiao, Nan Xu, Minghao Li, Lei Yu & Xin Li. (2022) CD20-specific chimeric antigen receptor-expressing T cells as salvage therapy in rituximab-refractory/relapsed B-cell non-Hodgkin lymphoma. Cytotherapy 24:10, pages 1026-1034.
Crossref
Crossref
Sarah E. Lovelace, Sabrina Helmold Hait, Eun Sung Yang, Madison L. Fox, Cuiping Liu, Misook Choe, Xuejun Chen, Elizabeth McCarthy, John-Paul Todd, Ruth A. Woodward, Richard A. Koup, John R. Mascola & Amarendra Pegu. (2022) Anti-viral efficacy of a next-generation CD4-binding site bNAb in SHIV-infected animals in the absence of anti-drug antibody responses. iScience 25:10, pages 105067.
Crossref
Crossref
Julie Lasvergnas, Marie Naigeon, Kader Chouahnia, Laurent Zelek, Nathalie Chaput & Boris Duchemann. (2022) Adoptive cell therapies in thoracic malignancies. Cancer Immunology, Immunotherapy 71:9, pages 2077-2098.
Crossref
Crossref
Maciej Borówka, Stanisław Łącki-Zynzeling, Michał Nicze, Sylwia Kozak & Jerzy Chudek. (2022) Adverse Renal Effects of Anticancer Immunotherapy: A Review. Cancers 14:17, pages 4086.
Crossref
Crossref
Yifan Ren, Jialong Song, Xinyi Li & Na Luo. (2022) Rationale and Clinical Research Progress on PD-1/PD-L1-Based Immunotherapy for Metastatic Triple-Negative Breast Cancer. International Journal of Molecular Sciences 23:16, pages 8878.
Crossref
Crossref
Josée Golay, Alain E. Andrea & Irene Cattaneo. (2022) Role of Fc Core Fucosylation in the Effector Function of IgG1 Antibodies. Frontiers in Immunology 13.
Crossref
Crossref
Rong Chen, Yuling Chen, Ping Xiong, Daniella Zheleva, David Blake, Michael J. Keating, William G. Wierda & William Plunkett. (2022) Cyclin-dependent kinase inhibitor fadraciclib (CYC065) depletes anti-apoptotic protein and synergizes with venetoclax in primary chronic lymphocytic leukemia cells. Leukemia 36:6, pages 1596-1608.
Crossref
Crossref
Xiaonan Hong, Yuqin Song, Yuankai Shi, Qingyuan Zhang, Wei Guo, Gang Wu, Junmin Li, Jifeng Feng, Anastasiia Kinkolykh, Andrea Knapp & Tongyu Lin. (2022) Efficacy and safety of obinutuzumab for the first-line treatment of follicular lymphoma: a subgroup analysis of Chinese patients enrolled in the phase III GALLIUM study. Chinese Medical Journal 135:4, pages 433-440.
Crossref
Crossref
Esther S. Frisch, Roxanne Pretzsch & Martin S. Weber. (2021) A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues. Neurotherapeutics 18:3, pages 1602-1622.
Crossref
Crossref